Correlation between plasma transforming growth factor-β1 and second primary breast cancer in a chemoprevention trial
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (7) , 999-1003
- https://doi.org/10.1016/s0959-8049(97)10170-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Contralateral breast cancer: annual incidence and risk parameters.Journal of Clinical Oncology, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male SmokersNew England Journal of Medicine, 1994
- Mechanistic considerations in chemopreventive drug developmentJournal of Cellular Biochemistry, 1994
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- Chemoprevention of cancerThe Lancet, 1993
- Retinoid Modulation of Insulin-Like Growth Factor-Binding Proteins and Inhibition of Breast Carcinoma Proliferation*Endocrinology, 1991
- Roles for transforming growth factors-β in the genesis, prevention, and treatment of breast cancerPublished by Springer Nature ,1991
- The Transforming Growth Factor-βsPublished by Springer Nature ,1990
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987